The US Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia.Manufacturer CSL Behring set the price at $3.5 million per treatment, making it the most expensive drug in the world.Hemgenix is a gene therapy to treat adults with hemophilia B, a genetic bleeding disorder in which people do not produce a protein needed to create blood clots.
[
add
]
[
|
|
...
]